TRIBUTE: Một thử nghiệm giai đoạn III về kombin thuốc Erlotinib Hydrochloride (OSI-774) kết hợp với hóa trị Carboplatin và Paclitaxel trong ung thư phổi không tế bào nhỏ giai đoạn tiến triển
Tóm tắt
Từ khóa
Tài liệu tham khảo
Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000: The global picture. Eur J Cancer 37:S4,2001-S66, (suppl 8)
Declaration of Helsinki . Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, and the 35th World Medical Assembly, Venice, Italy, October, 1983
DakoCytomation PharmDx™ kit . Carpenteria, CA, DakoCytomation Inc, 2004
Tran HT, Zinner R, Blumenschein GR, et al: Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial of paclitaxel (pac) and carboplatin (c) combined with erlotinib (e) or placebo in patients with advanced non-small cell lung cancer (NSCLC). J Clin Oncol 22:139,2004, (abstr 2050)
Tracy S, Mukohara T, Hansen M, et al: Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res 68:7241,2004-7244,
Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, et al: Chromosomal alterationsin lung adenocarcinoma from smokers and nonsmokers. Cancer Res 61:1309,2001-1313,